Cargando...
EXTH-63. EFFICIENT ADCC-MEDIATED KILLING OF MALIGNANT MENINGIOMA CELLS USING AVELUMAB AND AN ENGINEERED HIGH AVIDITY NATURAL KILLER CELL LINE, haNK
BACKGROUND: Meningiomas are the most common primary brain tumor. Standard of care includes surgery and radiation therapy. There are no known effective medical therapies for recurrent meningioma, particularly for WHO grades II and III. As such, novel therapeutic approaches are desperately needed. PD-...
Gardado en:
| Publicado en: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216200/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.410 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|